Home Assessing the efficacy of a hybrid closed loop system in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes
Article
Licensed
Unlicensed Requires Authentication

Assessing the efficacy of a hybrid closed loop system in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes

  • Andrea Granados ORCID logo EMAIL logo , Juliana Orrego Castellanos ORCID logo , Andrea Martinez Sanchez ORCID logo , Maria Jose Giraldo ORCID logo and Adriana Carrillo-Iregui ORCID logo
Published/Copyright: February 17, 2025

Abstract

Objectives

Despite improved outcomes in the use of a hybrid closed loop system (HCLS), significant disparities in the application of this technology exist among youth with type 1 diabetes (T1DM). The study aimed to evaluate the impact of a tubeless HCLS on glycemic outcomes in a pediatric racial-ethnic minority population.

Methods

A retrospective, single-center study included youth with T1D initiating HCLS Omnipod 5. Outcomes included HbA1c, continuous glucose monitor variables, BMI Z score, and episodes of diabetic ketoacidosis (DKA). Outcomes were compared from baseline, 3 and 6 months of Omnipod 5 start.

Results

The study included 174 participants, aged between 2 and 22 years, with a mean age of 7.9 ± 3.7 years. Hispanics constituted 87.3 % (152) of the cohort, with 53 % males and 47 % females. Insurance coverage was 56.9 % public, 42.5 % private, and 0.5 % uninsured. Baseline HbA1c level was 8.0 % ± 1.7, 7.3 % ± 1.1 at 3 months and 7.3 % ± 1.1 at 6 months (p<0.001). Glucose time in range (TIR) was 54.5 % at baseline to 61.9 % at 3 months, and 60.5 % at 6 months (p<0.001). Notably, there were no changes in BMI z-scores or DKA episodes following the initiation of the HCLS Omnipod 5.

Conclusions

The study showed that a tubeless HCLS significantly improved glycemic control in a pediatric minority cohort with T1DM, without affecting BMI Z-scores or increasing DKA episodes. Ongoing efforts to address disparities in diabetes technology access are crucial for optimizing care and alleviating the burden on individuals with T1DM across racial backgrounds.


Corresponding author: Andrea Granados, MD, Department of Pediatric Endocrinology and Diabetes, Nicklaus Children’s Hospital, 3100 SW 62 Av., Suite 102, Miami, FL 33155, USA, E-mail:
The manuscript has been presented to the Endocrine Society Conference Abstract section. Boston MA. USA. June 1st 2024.

Acknowledgments

We would like to express our deepest gratitude to all the patients who participated in this study. Their willingness to contribute their time and experiences was invaluable to our research. We also extend our heartfelt thanks to the entire diabetes team, including the endocrinologists, diabetes educators, nurses, and support staff, for their unwavering dedication and expertise.

  1. Research ethics: Endocrinology umbrella 1-1249983 Approved in January of 2020.

  2. Informed consent: Consent not required.

  3. Author contributions: AC and AG contributed to the conception and design of the work. AC, AG, AM, JO and MG contributed to the acquisition of data for the work. AC, AG, AM contributed to the analysis of the data. AC, AG, AM, JO and MG contributed to the interpretation of data. AC, AG, AM, JO and MG drafted the manuscript, and all authors critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Streisand, R, Monaghan, M. Young children with type 1 diabetes: challenges, research, and future directions. Curr Diabetes Rep 2014;14:520. https://doi.org/10.1007/s11892-014-0520-2.Search in Google Scholar PubMed PubMed Central

2. American Diabetes Association Professional Practice Committee. Improving care and promoting health in populations: standards of care in diabetes – 2024. Diabetes Care 2024;47:11–9. https://doi.org/10.2337/dc24-S001.Search in Google Scholar PubMed PubMed Central

3. Malik, FS, Sauder, KA, Isom, S, Reboussin, BA, Dabelea, D, Lawrence, JM, et al.. Trends in glycemic control among youth and young adults with diabetes: the SEARCH for diabetes in youth study. Diabetes Care 2002;45:285–94. https://doi.org/10.2337/dc21-0507.Search in Google Scholar PubMed PubMed Central

4. Nevo-Shenker, M, Phillip, M, Nimri, R, Shalitin, S. Type 1 diabetes mellitus management in young children: implementation of current technologies. Pediatr Res 2022;87:624–9. https://doi.org/10.1038/s41390-019-0665–4.10.1038/s41390-019-0665-4Search in Google Scholar PubMed

5. Borus, JS, Laffel, L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr 2010;22:405. https://doi.org/10.1097/MOP.0B013E32833A46A7.Search in Google Scholar PubMed PubMed Central

6. Ng, SM, Wright, NP, Yardley, D, Campbell, F, Randell, T, Trevelyan, N, et al.. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus – a National health service pilot initiative in England. Diabet Med 2023;40:e15015. https://doi.org/10.1111/DME.15015.Search in Google Scholar

7. Ware, J, Boughton, CK, Allen, JM, Wilinska, ME, Tauschmann, M, Denvir, L, et al.. Articles Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health 2022;4:245–55. https://doi.org/10.1016/S2589-7500(22)00020-6.Search in Google Scholar PubMed

8. Abraham, MB, Martin, DB, Smith, GJ, Dart, J, Fairchild, JM, KIng, BR, et al.. Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes A randomized clinical trial visual abstract supplemental content. JAMA Pediatr 2021;175:1227–35. https://doi.org/10.1001/jamapediatrics.2021.3965.Search in Google Scholar PubMed PubMed Central

9. Kahkoska, AR, Pokaprakarn, T, Rumay Alexander, G, Crume, TL, Dabelea, D, Divers, J, et al.. The impact of racial and ethnic health disparities in diabetes management on clinical outcomes: a reinforcement learning analysis of health inequity among youth and young adults in the SEARCH for diabetes in youth study. Diabetes Care 2022;45. https://doi.org/10.2337/dc21-0496.Search in Google Scholar PubMed PubMed Central

10. Everett, EM, Wright, D, Williams, A, Divers, J, Pihoker, C, Liese, AD, et al.. A longitudinal view of disparities in insulin pump use among youth with type 1 diabetes: the SEARCH for diabetes in youth study. Diabetes Technol Therapeut 2023;25:131. https://doi.org/10.1089/DIA.2022.0340.Search in Google Scholar PubMed PubMed Central

11. Charlew, S, Gomez, B, Butler, A, Hempe, J, Compton, T, Mercante, D, et al.. Predictors of Glycemic control in children with type 1 dibetes: the importance of race. J Diabetes Complicat 2000;14:71–7.10.1016/S1056-8727(00)00072-6Search in Google Scholar PubMed

12. Redondo, MJ, Libman, I, Cheng, P, Kollman, C, Tosur, M, Gal, RL, et al.. Racial/ethnic minority youth with recent-onset type 1 diabetes have poor prognostic factors. Diabetes Care 2018;41:dc172335. https://doi.org/10.2337/dc17-2335.Search in Google Scholar PubMed

13. Ware, J, Allen, JM, Boughton, CK, Wilinska, ME, Hartnell, S, Thankamony, A, et al.. Randomized trial of closed-loop control in very young children with type 1 diabetes. N Engl J Med 2022;386:209–19. https://doi.org/10.1056/NEJMoa2111673.Search in Google Scholar PubMed

14. Sherr, JL, Bode, BW, Forlenza, GP, Laffel, LM, Schoelwer, MJ, Buckingham, BA, et al.. Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial. Diabetes Care 2022;45:1907–10. https://doi.org/10.2337/dc21-2359.Search in Google Scholar PubMed PubMed Central

15. Sherr, JL, Buckingham, BA, Forlenza, GP, Galderisi, A, Ekhlaspour, L, Wadwa, RP, et al.. Safety and performance of the Omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 Days under free-living conditions. Diabetes Technol Therapeut 2020;22:174. https://doi.org/10.1089/DIA.2019.0286.Search in Google Scholar PubMed PubMed Central

16. Brown, SA, Forlenza, GP, Bode, BW, Pinsker, JE, Levy, CJ, Criego, AB, et al.. Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care 2021;44:1630. https://doi.org/10.2337/DC21-0172.Search in Google Scholar PubMed PubMed Central

17. Marks, BE, Meighan, S, Zehra, A, Douvas, JL, Rearson, A, Suresh, R, et al.. Real-world glycemic outcomes with early Omnipod 5 Use in youth with type 1 diabetes. Diabetes Technol Therapeut 2023;25:587–95. https://doi.org/10.1089/dia.2023.0337.Search in Google Scholar PubMed PubMed Central

18. Blair, IV, Steiner, JF, Fairclough, DL, Hanratty, R, Price, DW, Hirsh, HK, et al.. Clinicians’ implicit ethnic/racial bias and perceptions of care among Black and Latino patients. Ann Fam Med 2013;11:43–52. https://doi.org/10.1370/AFM.1442.Search in Google Scholar

19. Loomba, L, Bonanno, S, Arellano, D, Crossen, S, Glaser, N. Original paper disparities in insulin pump use among Spanish-speaking children with type 1 diabetes compared to their non-Hispanic White peers: mixed methods study. JMIR Diabetes 2023;8:e45890. https://doi.org/10.2196/45890.Search in Google Scholar PubMed PubMed Central

Received: 2024-11-06
Accepted: 2025-01-23
Published Online: 2025-02-17
Published in Print: 2025-04-28

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Diabetes distress, depression, and future glycemic control among adolescents with type 1 diabetes
  4. Is oxytocin related to psychiatric symptoms in adolescents with obesity?
  5. Associations between body mass index and sleep duration in Brazilian children and adolescents: the moderating role of screen time
  6. The transfer of care experience in young adults with type 1 diabetes
  7. Assessing the efficacy of a hybrid closed loop system in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes
  8. Do children with type 1 diabetes mellitus remain protected against hepatitis B?
  9. Influence of excess weight on metabolic risk factors in Argentinian preschool children
  10. Causal associations between childhood obesity and delayed puberty or height: a bidirectional two-sample Mendelian randomization study
  11. Differentiating true precocious puberty and puberty variants in consecutive 275 girls: a single center experience
  12. Development of bone mineral density and content in children with cerebral palsy: a retrospective, longitudinal study
  13. Insights in non-CAH pediatric primary adrenal insufficiency: a single-center experience from India
  14. Effect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye
  15. Clinical and laboratory characteristics of propionic acidemia in a Turkish cohort
  16. Short Communication
  17. The impact of the COVID-19 pandemic on DKA severity in Black and White pediatric patients
  18. Case Reports
  19. Evinacumab as an adjunct to lipid apheresis in an infant with homozygous familial hypercholesterolemia
  20. DNA ligase IV deficiency identified in a patient with hypergonadotropic hypogonadism: a case report
  21. Moebius syndrome and hypopituitarism: a case of multiple pituitary hormone deficiency and revision of the literature
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2024-0535/html
Scroll to top button